Recruitment Notification for Young Professional-I under Shrimp Pathogen Therapeutics Project at ICAR-CIBA

by Fishery News

Applications are invited from eligible candidates for the recruitment of Young Professional-I (1 Post) on a purely temporary basis under the institute project titled “Evaluation of Therapeutics Against Shrimp Pathogens” at ICAR-CIBA, Chennai, Tamil Nadu.

Post:

Young Professional-I (1 Post)

Project Name:

Evaluation of Therapeutics Against Shrimp Pathogens

Duration:

12 Months

Essential Qualification:

  • Graduate degree in Fisheries Science, Aquaculture, Marine Biology, Biotechnology, or B.Tech in Biotechnology, or equivalent from a recognized university/college.

Desirable:

  • Experience in molecular work (PCR, qPCR), bacteriology, histology, and molecular docking.
  • Working knowledge of scientific data and statistical analysis.

Emoluments:

Rs 30,000/- (Consolidated) per month

Age Limit:

  • Maximum 35 years for men and 40 years for women as of the date of the interview.
  • Age relaxation for SC/ST/OBC candidates will be as per the rules.

Last Date for Submission of Biodata:

22nd September 2024

Date & Time of Interview:

Will be intimated by mail.

Mode of Interview:

Suitable online platform or personal interview.

Interested candidates fulfilling the above criteria may send their applications in the prescribed proforma along with their biodata via email to sathishciba88@gmail.com / manofpm@gmail.com on or before 22nd September 2024. Applications received after the prescribed last date will not be considered.

Communication will be sent only to shortlisted candidates by email for attending the interview. The shortlisted candidates must attend the online interview with the required documents. The Director, ICAR-CIBA, reserves the right to accept or reject any applications. ICAR-CIBA will not correspond with applicants regarding the non-selection for the interview.

For more info visit ICAR-CIBA official website

You may also like

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Shares